cabazitaxel

Ukraine

Drugs containing this active substance

  • CABAZITAXEL ACCORD

    The drug is indicated for the treatment of adult patients with hormone-refractory metastatic prostate cancer who have previously received treatment with a docetaxel-based regimen.

    Form: concentrate for infusion solution

    Active substance Dosage
    cabazitaxel 20 mg/ml

    ATC: L01CD04

    Manufacturer: Accord Healthcare Polska Sp. z o.o. Warehouse Importer (Responsible for batch release)

  • KAZEXA

    It is used for the treatment of adult patients with hormone-refractory metastatic prostate cancer who have previously undergone treatment with a docetaxel-based regimen. The drug is prescribed in combination with prednisone or prednisolone.

    Form: concentrate for infusion solution

    Active substance Dosage
    cabazitaxel 60 mg in 1.5 ml 40 mg/ml

    ATC: L01CD04

    Manufacturer: Hetero Labs Limited